Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
India
100%
Heart Failure
100%
Heart Failure Patients
100%
Clinical Presentation
100%
Presentation Management
100%
90-day Outcomes
100%
Kerala
100%
Trivandrum
100%
Medical Treatment
42%
Confidence Interval
28%
90-day Mortality
28%
Left Ventricular Systolic Dysfunction
28%
Ischemic Heart Disease
28%
Guideline-based
28%
High Risk
14%
Mean Standard Deviation
14%
High Mortality
14%
Clinical Characteristics
14%
Heart Failure with Preserved Ejection Fraction (HFpEF)
14%
High Prevalence
14%
Length of Hospital Stay
14%
Old Age
14%
In-hospital Mortality
14%
Low Education
14%
Published Data
14%
Medical Care
14%
Serum Creatinine
14%
Angiotensin-converting Enzyme Inhibitor (ACEi)
14%
All-cause Mortality
14%
Ejection Fraction
14%
New York Heart Association Functional Class
14%
Long Length
14%
Hospital Admission
14%
Primary Diagnosis
14%
Hospital-based
14%
Hospital Stay
14%
In-hospital Outcomes
14%
Angiotensin Receptor Blockers
14%
Beta-blockers
14%
At Discharge
14%
Heart Disease Diagnosis
14%
Mortality Data
14%
Heart Failure Etiology
14%
Rural Hospitals
14%
Aldosterone Receptor Blockers
14%
Medicine and Dentistry
Congestive Heart Failure
100%
Combination Therapy
33%
Mortality Rate
22%
Ischemic Heart Disease
22%
Left Ventricular Systolic Dysfunction
22%
Prevalence
11%
Heart Failure with Preserved Ejection Fraction
11%
New York Heart Association Class
11%
Hospital Mortality
11%
Creatinine
11%
Ejection Fraction
11%
Medical Care
11%
All Cause Mortality
11%
ACE Inhibitor
11%
Angiotensin Receptor Antagonist
11%
Beta Adrenergic Receptor Blocking Agent
11%
Aldosterone Receptor
11%
Receptor Blocking Agent
11%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Combination Therapy
33%
Mortality Rate
22%
Ischemic Heart Disease
22%
Left Ventricular Systolic Dysfunction
22%
Prevalence
11%
Creatinine
11%
Dipeptidyl Carboxypeptidase Inhibitor
11%
All Cause Mortality
11%
Hospital Mortality
11%
Angiotensin Receptor Antagonist
11%
Heart Failure with Preserved Ejection Fraction
11%
Beta Adrenergic Receptor Blocking Agent
11%
Receptor Blocking Agent
11%
Aldosterone Receptor
11%